Universe Pharmaceuticals Inc
2 hedge funds and large institutions have $5.81K invested in Universe Pharmaceuticals Inc in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
50% less funds holding
Funds holding: 4 → 2 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
83% less capital invested
Capital invested by funds: $33.7K → $5.81K (-$27.8K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$9K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$6.65K |
| 3 |
HF
HRT Financial
New York
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Acadian Asset Management
Boston,
Massachusetts
| $5K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $808 | +$1.01K | +1 | New |
|
|
3
Renaissance Technologies
New York
| – | -$9K | -7 | Closed |
|
|
HF
4
HRT Financial
New York
| – | -$6K | -5 | Closed |
|
|
TSS
5
Two Sigma Securities
New York
| – | -$6.65K | -5 | Closed |
|
UPC Hedge Fund Activity: Q3 2023 in Review
2 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q3 2023, worth a combined $5.81K — down 83% from $33.7K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of UPC and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $1.01K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $9K sold.
- 2 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q3 2023, down from 4 in Q2 2023.
- Funds reported $5.81K of Universe Pharmaceuticals Inc stock for Q3 2023, down 83% quarter-over-quarter.
- 1 fund opened new Universe Pharmaceuticals Inc positions in Q3 2023 and 3 closed out, a net change of -2 holders.
- The largest Universe Pharmaceuticals Inc buyer in Q3 2023 was UBS Group, an estimated $1.01K added.
- The largest Universe Pharmaceuticals Inc seller in Q3 2023 was Renaissance Technologies, an estimated $9K sold.
Based on aggregated 13F filings for Q3 2023.